Stories by PRNEWS

What can PR professionals learn from the life experiences of Thomas R. Martin? No flippancy intended, but where can we start? As one of the most influential and successful PR practitioners of our time, Martin… Continued

Going Dutch It is not unusual for a PR professional to write a book about PR. But it is unusual for a PR professional to write a book on how the Netherlands fought to preserve… Continued

(This week, PR News editors Phil Hall and Aaron Jenkins hop all over a crisis communications story involving a man in a frog costume.) PHIL: This column involves PR, HR and crisis communications. I read… Continued

First there were online communities that enabled you to post your favorite video clips for the world to see. Then came “monetized” video sites that offered a share of revenues for those whose who were… Continued

Any PR professional involved in book publishing can confirm the challenges of getting people aware of new titles. This week, we hopscotch from Louisiana to Tanzania to Australia to judge campaigns regarding the availability of… Continued

Company: Transport for London Timeframe: July 2005 July 7, 2005, should have been a day of cheers and clanging pint glasses in London. The day before, the city learned it had edged out Paris to… Continued

In the July 17 article “Word-of-Mouth PR Redefines The Concept of Lip Service”, the president of BzzAgent was incorrectly identified: His name is Dave Balter, not Dave Bartel. Also, the article stated BzzAgent has a… Continued

Question: Do you think the CEOs of the nation’s major corporations are genuinely concerned with how the public perceives their executive compensation packages? ANSWER: This won’t win us many friends in the C-suite, but the… Continued

By Frank Ovaitt The squeaky wheel gets greased. But what if a different wheel is about to fall off the car? “How much attention does each stakeholder group deserve or require?” is a central question… Continued

Why People Dislike Drug Companies An independent survey recently conducted by G&S Research polled 376 pharmaceutical sales representatives about public perception of drug companies. The survey found 85% of the sales reps thought public opinion… Continued